.

 

Boston Institute of Biotechnology develops and runs reproducible, robust and scalable microbial fermentation and mammalian cell culture process for the production of therapeutic protein and antibodies. We have years of experience with fermentation and mammalian cell culture technologies to meet the future commercial requirement such as high throughput process development technologies, disposable mini bioreactors, high cell density screening, and complex system optimization.

Our key equipment includes Applikon micro-Matrix, DASGIP® Benchtop Bioreactors, 50L Sartorius D30 Bioreactor, mass flow controllers for gas mixing, Terumo sterile tubing welder, biosafety cabinet, Nova Bioprofile 400 Analyzer, YSI, Innova 4330 shaker incubator and Infor HT Multitron shaker incubators, etc.